特立帕肽(Teriparatide)作为一种骨形成促进药物,近年来在老年性骨质疏松症的治疗中展现了显著的疗效。本文综述了特立帕肽在老年性骨质疏松症中的应用现状,包括其作用机制、临床效果、安全性及未来研究方向,旨在为老年性骨质疏松症的...特立帕肽(Teriparatide)作为一种骨形成促进药物,近年来在老年性骨质疏松症的治疗中展现了显著的疗效。本文综述了特立帕肽在老年性骨质疏松症中的应用现状,包括其作用机制、临床效果、安全性及未来研究方向,旨在为老年性骨质疏松症的治疗提供参考。Teriparatide, as a bone formation promoting drug, has shown remarkable efficacy in the treatment of senile osteoporosis in recent years. This article summarizes the current application of Teriparatide in senile osteoporosis, including its mechanism of action, clinical effects, safety and future research direction, aiming to provide a reference for the treatment of senile osteoporosis.展开更多
文摘特立帕肽(Teriparatide)作为一种骨形成促进药物,近年来在老年性骨质疏松症的治疗中展现了显著的疗效。本文综述了特立帕肽在老年性骨质疏松症中的应用现状,包括其作用机制、临床效果、安全性及未来研究方向,旨在为老年性骨质疏松症的治疗提供参考。Teriparatide, as a bone formation promoting drug, has shown remarkable efficacy in the treatment of senile osteoporosis in recent years. This article summarizes the current application of Teriparatide in senile osteoporosis, including its mechanism of action, clinical effects, safety and future research direction, aiming to provide a reference for the treatment of senile osteoporosis.
